Official recall notice

FDA DrugClass INotable

FDA Recall: Rising Pharma Holdings Inc.: Cetirizine Hydrochloride Tablets USP 5 mg

Recall date
2026-07-20
Category
Drug
FDA class
Class I

Why it was recalled

Hazard

Potential cross contamination with Ranitidine

Product description

Potential cross contamination with Ranitidine

Affected products

Lots: GY825029, GY825030, GY825031, GY825032, expires: 2028-OCT

Verify with the official notice →
Share:

Related Recalls

2026-09-21 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL)
Par Pharmaceutical
2026-09-21 · FDA_DRUG
FDA Recall: ICU Medical LLC: 0.9% Sodium Chloride Injection, USP, 100 mL
ICU Medical LLC
2026-09-16 · FDA_DRUG
FDA Recall: Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Off
ImprimisRx NJ LLC
2026-09-16 · FDA_DRUG
FDA Recall: Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharm
Ajanta Pharma USA Inc